Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Minimizing the Risk of Teratogenic Substance Exposure for Pregnant Compounding Pharmacists

Author(s):  Paoletti James E, Benavides Tomas J

Issue:  Nov/Dec 1998 - Environmental Compounds
View All Articles in Issue

Page(s):  414-415

Minimizing the Risk of Teratogenic Substance Exposure for Pregnant Compounding Pharmacists Page 1
Minimizing the Risk of Teratogenic Substance Exposure for Pregnant Compounding Pharmacists Page 2

Download in electronic PDF format for $75

Abstract:  The handling of chemicals in the compounding lab by a pregnant woman presents a unique problem. Proper mask, gown and gloves should be worn any time a pregnant woman enters the lab or cleanroom. Chemical agents known or thought to possibly cause fetal damage must be completely avoided by pregnant lab personnel. The authors include a list of known or suspected teratogenic substances (not all inclusive).

Related Keywords: Antineoplastics, Anticonvulsants, Antitussives, Nsaids, Analgesics, Coagulants, Anticoagulants, Diuretics, Angiotensin, Antihypertensives, Antilipemic, Antisecretory, Gallsone, Sympathomimetics, Sympatholytics, Antidirrheals, Toxins, Hallucinogens

Related Categories: CANCER AND AIDS, SUPPORT

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Minimizing the Risk of Teratogenic Substance Exposure for Pregnant Compounding Pharmacists
Paoletti James E
, Benavides Tomas J
Nov/Dec 1998
Pg. 414-415

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Containment of Hazardous Particulates in the Compounding Pharmacy
Allen Loyd V Jr
Jul/Aug 2003
Pg. 281-285

Antineoplastic Drug Contamination on the Outside of Prepared Infusion Bags
Breukels Oscar
, van der Gronde Toon, Simons-Sanders Kathleen, Crul Mirjam
Jul/Aug 2018
Pg. 345-349

Development of Stable and Simple Finasteride 333-μg/mL Suspensions that Minimize Occupational Exposure
Ma Nathan
, Perks William, Law Shirley, Iazzetta John, Walker Scott
Nov/Dec 2020
Pg. 519-527

PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Allen Loyd V Jr
Sep/Oct 2021
Pg. 356

Analgesic NSAID Suppositories
Allen Loyd V Jr
Jan/Feb 2002
Pg. 40

Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States
Lobb William B
, Wilkin Noel E, Holmes Erin R
Nov/Dec 2015
Pg. 514-520

Basics of Compounding for Cold Sores or Fever Blisters
Allen Loyd V Jr
May/Jun 2004
Pg. 206-209

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding
Soefje Scott
, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Nov/Dec 2021
Pg. 515-522

Evaluation of Closed-system Transfer Devices in Reducing Potential Risk for Surface Contamination Following Simulated Hazardous-drug Preparation and Compounding (Reprint)
Soefje Scott
, Rickabaugh Keith, Rajkumar Rahul, Wall Kathryn P
Jan/Feb 2022
Pg. 72-79

Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
Sep/Oct 2021
Pg. 358-362

The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene
, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jan/Feb 2014
Pg. 6-12

Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser
Christiansen Joel
, White Lyndell
Jul/Aug 2010
Pg. 310-314

Minimizing the Risk of Cholesterol-Lowering Therapy
Pratt Sam
Sep/Oct 2001
Pg. 362-364

Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs
Harrington Catherine A
, Cauffield Jacintha
May/Jun 2005
Pg. 201-205

Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk
Cabaleiro Joe
Jan/Feb 2020
Pg. 21-27

Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Brown Scott
, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010
Pg. 182-192

Patient-centered Care as Value-added Service by Compounding Pharmacists
McPherson Timothy B
, Fontane Patrick E, Day Jonathan R
Jul/Aug 2013
Pg. 339-343

Return to Top